Apothecus Pharmaceuticals

For decades scientists and researchers have tried to develop the perfect contraceptive for both men and women. Unobtrusiveness, effectiveness, safety, ease of use, portability and cost has always been the unattainable combination of criteria for formulating a new drug in this category. Despite the array of contraceptive choices, there are over 3,000,000 unwanted pregnancies in the U.S. alone. It is obvious that millions of Americans use no form of contraception at all.

Until now, spermicides have been messy, irritating, awkward to administer and obtrusive to either or both partners.

VCF Vaginal Contraceptive Film delivers N-9 in the form of an ultrathin dissolving piece of transparent material. Unlike all other spermicides, VCF is undetectable by either partner. The reason is that its unique form contains far less inactive ingredient that is required in foams, gels, suppositories and creams to deliver the spermicide itself.

VCF Vaginal Contraceptive Film answers the questions by millions of consumers as to their need for the perfect contraceptive. VCF is the first non-invasive, non-hormonal contraceptive that neither partner can feel.

VCF Vaginal Contraceptive Film consists of a water-soluble square of film, approximately 2 x 2 inches, into which has been incorporated the potent non-ionic chemical spermicide nonylphnenoxypolyethoxyethanol (nonoxynol-9). The Federal Food and Drug AdministrationÃs advisory panel on human use has reviewed the ingredient nonoxynol-9 and rated it Category 1, safe and effective for use as OTC vaginal contraceptive in proper dosage. What sets VCF apart from competition is that VCF delivers an effective dose of N-9 with a minimum amount of inactive, messy ingredients and difficult application. There are no aerosol cans, no plastic applicators or other obtrusive, time-consuming and uncomfortable application methods. It is virtually undetectable to either partner.

Vaginal Contraceptive Film has been the subject of numerous safety and efficacy studies conducted worldwide. Over 30 studies in countries ranging from Great Britain to Japan have followed over 1,000 women through 10,000 menstrual cycles. Based on these studies, when used as directed, the product shows a Pearl Index failure rate of 5.9. What sets VCF apart from other products is the factor of compliance, a most important element in determining effectiveness. Once a woman tries VCF, she tends to continue to use the product because of its unobtrusiveness and acceptability to both sexual partners. This is the single most important issue in contraception.